Particle contamination of parenteralia and in-line filtration of proteinaceous drugs-Reference-Cited by-同舟云学术

Particle contamination of parenteralia and in-line filtration of proteinaceous drugs

Published:2015-12 Issue:2 Volume:496 Page:250-267
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Werner Benjamin Patrick^ORCID,Winter Gerhard

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference204 articles.

1. Abbokinase® [Package insert], 10/2002. Abbott Laboratories. North Chicago, IL.

2. Advate 250IU powder and solvent for solution for injection – ANNEX I – Summary of product characteristics, 03/2009. European Medicine Agency. London, GB.

3. Advate [Package insert], 06/2013. Baxter AG. Vienna, Austria.

4. Advate [Package insert], 07/2012. Baxter Healthcare Corporation. Westlake Village, CA.

5. Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics;Ahmadi;Pharm. Res.,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of tubing material on stability and filling accuracy of biologic drug product;International Journal of Pharmaceutics;2024-04

2. Shear stress as a driver of degradation for protein-based therapeutics: More accomplice than culprit;International Journal of Pharmaceutics;2024-01

3. Characterization of Silicone from Closed System Transfer Devices and its Migration into Pharmaceutical Drug Products;Journal of Pharmaceutical Sciences;2023-11

4. A Survey on Handling and Administration of Therapeutic Protein Products in German and Swiss Hospitals;Journal of Pharmaceutical Sciences;2023-09

5. Comparative study between a gravity-based and peristaltic pump for intravenous infusion with respect to the generation of proteinaceous microparticles;International Journal of Pharmaceutics;2023-07